A PYMNTS Company

All Eyes On Antitrust Enforcement In China’s Pharmaceutical Industry

BY | July 17, 2016

By Adrian Emch & Jiaming Zhang – August 1, 2016 marks the eighth anniversary of the entry into effect of China’s Anti-Monopoly Law (“AML”). Enforcement of the law has gone…

By Adrian Emch & Jiaming Zhang
August 1, 2016 marks the eighth anniversary of the entry into effect of China’s Anti-Monopoly Law (“AML”). Enforcement of the law has gone through various phases, with the peak – at least in terms of press coverage – during 2014, culminating in the Qualcomm decision by the National Development and Reform Commission in February 2015.
Since the 2015 Qualcomm decision, Chinese antitrust enforcement has been less headline-grabbing and, generally s...

THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.236.143.154

Please verify email or join us to access premium content!